Sun Pharma buying Organon $11.75B, largest Indian pharma acquisition
NewsBytes | April 28, 2026 7:42 PM CST
Sun Pharma expects manageable debt
After the buyout, Sun Pharma expects its debt to stay manageable, thanks to strong cash flow and over $350 million in planned cost savings.
The company also plans to use Organon's worldwide network to push its specialty medicines further, aiming for bigger global reach and stronger earnings.
READ NEXT
-
800 Hours And 3,000 Crystals: Gaurav Gupta Crafts Lady Gaga And Doechii’s Dramatic Bodysuits For The Devil Wears Prada 2
-
Skin Care: Is skin getting worse as the weather changes? This routine will save your skin!
-
Who wrote Ramcharitmanas, Tulsidas or Valmiki? Know the real truth
-
Want to get rid of spots and blemishes? Get beautiful and glowing skin with Patanjali Beauty Cream, know its benefits
-
Successful Elite Marriages: Psychology & The Best Matrimony Site
